Breast cancer female and Osteomyelitis

Summary:

Osteomyelitis is found among people with Breast cancer female, especially for people who are female, 60+ old.

The study analyzes which people have Osteomyelitis with Breast cancer female. It is created by eHealthMe based on reports of 36 people who have Breast cancer female from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 12, 2022

36 people who have Breast Cancer Female and Osteomyelitis are studied.


What is Breast cancer female?

Breast cancer female is found to be associated with 991 drugs and 563 conditions by eHealthMe.

What is Osteomyelitis?

Osteomyelitis (infection of bone) is found to be associated with 1,849 drugs and 1,266 conditions by eHealthMe.

Number of Osteomyelitis in Breast cancer female reports submitted per year:

Would you have Osteomyelitis when you have Breast cancer female?

Gender of people who have Breast Cancer Female and experienced Osteomyelitis *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Breast Cancer Female and experienced Osteomyelitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.94 %
  • 40-49: 5.88 %
  • 50-59: 20.59 %
  • 60+: 70.59 %

Common co-existing conditions for these people *:

  1. Metastases To Bone (cancer spreads to bone): 4 people, 11.11%
  2. Nausea And Vomiting: 1 person, 2.78%
  3. Nausea (feeling of having an urge to vomit): 1 person, 2.78%
  4. Malignant Melanoma (skin cancer rises from melancytes): 1 person, 2.78%
  5. Indigestion: 1 person, 2.78%
  6. Hypersensitivity: 1 person, 2.78%
  7. Diabetes: 1 person, 2.78%
  8. Breast Cancer Metastatic: 1 person, 2.78%
  9. Breast Cancer: 1 person, 2.78%
  10. Bone Pain: 1 person, 2.78%

Common drugs taken by these people *:

  1. Zometa: 12 people, 33.33%
  2. Ibrance: 12 people, 33.33%
  3. Taxotere: 8 people, 22.22%
  4. Faslodex: 7 people, 19.44%
  5. Xeloda: 5 people, 13.89%
  6. Aromasin: 4 people, 11.11%
  7. Ellence: 3 people, 8.33%
  8. Herceptin: 3 people, 8.33%
  9. Dexamethasone: 3 people, 8.33%
  10. Arimidex: 3 people, 8.33%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 6 people, 16.67%
  2. Bone Disorder: 5 people, 13.89%
  3. Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 5 people, 13.89%
  4. Gingival Disorder (gum disease): 5 people, 13.89%
  5. Mouth Ulcers: 4 people, 11.11%
  6. Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 11.11%
  7. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 11.11%
  8. Cellulitis (infection under the skin): 4 people, 11.11%
  9. Back Pain: 4 people, 11.11%
  10. Impaired Healing: 4 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Osteomyelitis?

Check whether Osteomyelitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Osteomyelitis:

Common drugs associated with Osteomyelitis:

All the drugs that are associated with Osteomyelitis:

Common conditions associated with Osteomyelitis:

All the conditions that are associated with Osteomyelitis:

How the study uses the data?

The study is based on Osteomyelitis and Breast cancer female, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: